Biopharma Update on the Novel Coronavirus: August 3
Eli Lilly announced it is moving into a late-stage, Phase III clinical trial for an antibody COVID-19 treatment. Recruitment will come from residents and …
The COVID Remedy
COVID-19 Information & Remedies